StonvexLoading…
StonvexStonvexStonvexCore line items from BUD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $59.32B | $59.77B | $59.38B | $57.79B |
Operating Income | $15.40B | $15.49B | $13.97B | $14.52B |
Net Income | $8.48B | $7.42B | $6.89B | $7.60B |
EPS (Diluted) | $3.39 | $2.86 | $2.60 | $2.91 |
Total Assets | $218.81B | $206.64B | $219.34B | $212.94B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $11.64B | $11.17B | $10.33B | $9.97B |
Free Cash Flow OCF − CapEx | $11.23B | $11.19B | $8.63B | $8.14B |
Shares Outstanding | 2.02B | 2.02B | 2.02B | 2.02B |